Learning outcome 2 Flashcards
Peripheral nervous system neurotransmitters
Acetylcholine, norepi, epi only. 21 known in CNS
Monoamines (CNS Neurotransmitters)
Dopamine, Epinephrine, Noreip, Serotonin
Amino acids (CNS Neurotransmitters)
Aspartate, GABA, Glutamate, Glycine
Purines (CNS Neurotransmitters)
Adenosine
Adenosine monophosphate and triphosphates
Opioid Peptides (CNS Neurotransmitters)
Dynorphins, Endorphins, Enkephalins
Nonopioid Peptides (CNS Neurotransmitters)
Neurotensin Oxytocin Somatostatin Substance P Vasopressin
Others (CNS Neurotransmitters)
Acetylcholine
Histamine
Increased therapeutic effects in CNS
Antipsychotics, antidepressants need to be taken for several weeks to develop full effects. Beneficial responses may be delayed as they result from adaptive changes, not direct effects.
Decreased side effects in CNS
Possible for therapeutic effects to remain the same as side effects decrease.
Phenobarb produces sedation but that declines while it still prevents seizures. Thought to be a cause of adaptive changes
Tolerance
Decreased response occurring in the course of prolonged drug use
Physical dependence
State in which abrupt discontinuation will precipitate withdrawal syndrome
Serendipitous
Occurred or happened by chance in a beneficial way
Difficulties finding new psych drugs
Can’t test on animals for obvious reasons, can’t test on healthy people because they have different effects
Opioid vs opiate
Opioid any drug (natural or synthetic) that has actions similar to morphine, where opiate applies only to compounds present in opium (morphine, codeine)
Three endogenous opioid peptides
Enkephalins, endorphins, dynorphins which serve as neurotransmitters, neurohormones, and neuromodulators
Three classes of opioid receptors
Mu, kappa, delta.
Opioid analgesics act primarily by activating mu and lesser extent kappa. Opioids generally don’t interact with delta but endogenous opioids act on all three.
Mu receptors
Responses include analgesia, respiratory depression, euphoria and sedation. Also related to physical dependence.
Analgesic defintion
Drugs that relieve pain without causing loss of consciousness
Psychotomimetic effects
relating to or denoting drugs that are capable of producing an effect on the mind similar to a psychotic state.
Kappa receptors
Produce analgesia, sedation and may underlie psychotomimetic effects
Partial agonist
Low to moderate receptor activation alone but blocks actions of full agonist if two are given together
Pure opioid agonists
Agonize Mu and Kappa, cause sedation, analgesia, euphoria, sedation, resp depression, dependence, cough suppression, and constipation
Morphine (prototype of strong opioid agonist)
Codeine (prototype of moderate to strong opioid agonist)
and other morphine like drugs
Agonist-antagonist opioids
Pentazocine (talwin, which is the prototype) , nalbuphine, butorphanol all antagonize mu and agonize kappa
Buprenorphine partial mu agonist, antagonist to kappa
Pure opioid antagonists
Antagonize mu and kappa, naloxone, naltrexone and others.
Methylnaltrexone to treat opioid induce constipation
Other effects of morphine
Resp depression, constipation, urinary retention, orthostatic hypotension, emesis, miosis, cough suppression, biliary colic.
Produce analgesia by mimicking actions of endogenous opioid peptides
Resp depression
At equinanalgesic doses, all cause resp depression to same extent by activation of mostly mu and lesser kappa
Resp depression kicks in 7 minutes after IV, 30 after IM, 90 after sub q and may persist 4-5 hours.
Morphine by spinal ejection might delay resp depression by hours
Constipation in opioids
Activating gut mu receptors suppresses propulsive intestinal contractions, intensifies nonpropulsive contractions, increase tone of anal sphincter, inhibit secretion of fluids into intestinal lumen.
Goal is to produce soft formed stool every 1-2 days.
Opioid constipation tx
Physical activity, increased fibre and fluids, enemas, senna to counter reduced bowel motility, docusate as stool softener, polyethylene glycol as osmotic laxative.
Rescue therapy is strong osmotic laxative like lactulose or sodium phosphate.
Methylnaltrexone blocks mu in intestines and is last resort (can’t cross BBB)
Orthostatic hypotension from opioids
Morphine like drugs block baroreceptor reflex and dilate peripheral arterioles and veins.
Peripheral vasodilation mostly from histamine
Morphine like drugs urinary retention
Increased tone of bladder sphincter, increase tone of detrusor muscle (elevating pressure within bladder, causing sense of urgency) and may suppress by diminishing awareness of fullness.
TCAs and antihistamines (antichols) worsen it, as well as underlying BPH
Also decreases renal blood flow which lowers urine production, and promotes releases of antidiuretic hormone
Morphine like drugs cough suppresion
May lead to accumulation. Act on medulla to suppress. Pts may need to be instructed to forcefully cough
Biliary colic morphine like drugs
Can induce spasm of bile duct, causing increased pressure in biliary tract causing epigastric distress to biliary colic.
In pts with biliary colic, opiods may intensify rather than relieve.
Morphine is worse than others for this
Emesis in morphine like drugs
Direct stimulation of chemoreceptor trigger zone of medulla. Greatest with initial dose. Occur in 15-40% of walking pts (uncommon in recumbent pts)
Stillness and antiemetics help this
Elevation of ICP in morphine like drugs
Indirect, as it suppresses resps which increase CO2 which dilates cerebral vasculature. ICP will remain normal if resps are kept normal
Dysphoria in morphine like drugs
Anxiety and unease. Uncommon if in pain, can happen if there is no pain
Sedation in morphine like drugs
Minimized with smaller more frequent dosing, short half lives, and small doses of CNS stimulants given with
Miosis in morphine like drugs
Can cause poor night vision
Birth defects in morphine like drugs
2-3x higher incidence. Worse during conception/early on.
Can cause congenital heart defects (av septal defects, hypoplastic left heart, conoventricular septal defects) and spina bifida and gastroschisis
Gastroschisis
Protrusion of intestine through abdo wall near umbilicus
Neurotoxicity in morphine like drugs
Delirium, agitation, myoclonus, hyperalgsia.
Risk factors are renal impairment, preexisting cognitive impairment, prolonged high dose use.
Manage with reduced dose and hydration and if long term use is indicated, occasionally switching
Long term use in morphine like drugs
Hormonal changes, altered immune function, decline in cortisol, increase in prolactin, decrease in LH and FSH
Pharmacokinetics of morphine
IM, IV, SUB q lasts 4-5 hours
Epidural, intracathecal up to 24 hours
Oral IR is 4-5 hours, ER up to 24.
Tolerance in morphine like drugs
Tolerance doesn’t develop to miosis and constipation
Cross-tolerance exists with other opiods but not other CNS depressants
Physical dependence in morphine like drugs
Short half lives give intense short withdrawal. Longer is longer
Withdrawal symptoms
Yawning, rhinorrhea, sweating (approx 10 hours after final dose) then anorexia, irritability, tremor, gooseflesh (term cold turkey) and peak with violent sneezing, weakness, nausea, vomiting, diarrhea, abdo cramps, bone and muscle pain, muscle spasm, kicking movements (kicking the habit)
Lasts 7-10 days in morphine
Rarely dangerous
Labor and delivery in morphine like drugs
Suppresses uterine contractions, resp depression in neonates